Rebecca Chambers Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 8 hours ago
Rebecca Chambers has an estimated net worth of at least $13.1 million*, as of today. They own 175,241 shares of VCYT stock. They have sold 82,933 shares of VCYT stock since 2021, for an estimated $2.7 million.
Rebecca Chambers $VCYT SEC Form 4 Insider Trading
Rebecca Chambers has filed a total of 10 insider trades in $VCYT since 2021. Their most recent trade was a sale of 1,961 shares, made on Jun 04, 2026. Their largest trade was a sale of 15,275 shares, made on Nov 12, 2024. We estimate that they now own 175,241 shares of $VCYT, worth an estimated $10.5 million.
Insider Trading at $VCYT
There have been a total of 159 insider trades reported at $VCYT since 2021, with 62,000 shares purchased and 1.3 million shares sold. The most active insider traders in $VCYT stock have been Giulia C Kennedy, Marc Stapley, and Annie Mcguire. The most recent trade was a sale of 529 shares reported by KARIN EASTHAM (None), made on Jun 18, 2026.
History of Insider Stock Trades by Rebecca Chambers
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VCYT
|
Sale | 1,961 | Jun 04, 2026 | June 4, 2026, 9:38 p.m. |
|
VCYT
|
Sale | 1,600 | Jun 04, 2026 | June 4, 2026, 9:38 p.m. |
|
VCYT
|
Sale | 4,400 | Mar 04, 2026 | March 6, 2026, 5:33 p.m. |
|
VCYT
|
Sale | 13,941 | Mar 04, 2026 | March 6, 2026, 5:33 p.m. |
|
VCYT
|
Sale | 8,537 | Dec 04, 2025 | Dec. 4, 2025, 8:44 p.m. |
|
VCYT
|
Sale | 4,741 | Dec 04, 2025 | Dec. 4, 2025, 8:44 p.m. |
|
VCYT
|
Sale | 7,000 | Nov 05, 2025 | Nov. 7, 2025, 5:10 p.m. |
|
VCYT
|
Sale | 527 | Feb 03, 2025 | Feb. 5, 2025, 5:49 p.m. |
|
VCYT
|
Sale | 7,000 | Dec 03, 2024 | Dec. 4, 2024, 5:59 p.m. |
|
VCYT
|
Sale | 15,275 | Nov 12, 2024 | Nov. 14, 2024, 5:35 p.m. |
NARI
|
Sale | 260 | Jun 21, 2024 | June 24, 2024, 5:48 p.m. |
|
NARI
|
Sale | 964 | May 20, 2024 | May 21, 2024, 6:57 p.m. |
OM
|
Sale | 16,727 | Jun 24, 2021 | June 24, 2021, 8 p.m. |
$VCYT Executives and Stock Owners with Insider Trades
-
Giulia C Kennedy, Chief Scientific & Med Officer
-
Marc Stapley, Chief Executive Officer
-
Annie Mcguire, SVP, General Counsel
-
John Leite, Chief Commercial Officer-CLIA
-
Rebecca Chambers, Chief Financial Officer
-
Bonnie H Anderson, Executive Chairwoman
-
Jonathan Wygant, VP, Chief Accounting Officer
-
Phillip G. Febbo, Chief Scientific & Med Officer
-
Annie Mcguire, EVP, General Counsel
-
John Leite, Global Chief Commercial Off
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.